AstraZeneca PLC (NYSE:AZN)

36.79
Delayed Data
As of May 21
 +0.46 / +1.27%
Today’s Change
28.43
Today|||52-Week Range
37.01
+6.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues26.0B24.7B22.9B22.7B
 
 
 
 
 
Cost of Goods Sold4.2B3.4B3.3B3.4B
 
 
 
 
 
Depreciation And Amortization3.1B2.7B2.3B2.5B
 
 
 
 
 
 
Operating ExpensesGross Income18.6B18.6B17.4B16.8B
 
 
 
 
 
General Expenses16.1B15.0B13.8B13.3B
 
 
 
 
 
Other Operating Expenses0.00-113.8M0.000.00
 
 
Research And Development4.9B5.6B5.6B5.5B
 
 
 
 
 
Total Operating Expenses23.5B21.0B19.4B19.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.5B3.7B3.6B3.5B
 
 
 
 
 
Extraordinary Credit15.9M387.4M996.4M32.3M
 
 
 
 
 
Extraordinary Charge-1.8B-2.1B-2.1B-2.2B
 
 
 
 
 
Interest Expense On Debt416.3M391.4M615.4M671.1M
 
 
 
 
 
Equity In Earnings-6.0M-16.0M-32.9M-55.6M
 
 
 
 
 
Other Expenses887.4M1.4B1.7B1.6B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.2B3.1B3.6B2.3B
 
 
 
 
 
Income Taxes-11.0M-242.6M-145.6M-647.9M
 
 
 
 
 
Minority Interest-2.0M-998.4K-92.8M-134.4M
 
 
 
 
 
Net Income1.2B2.8B3.5B3.0B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.49$1.11$1.38$1.20
 
 
 
 
 
EPS Diluted$0.49$1.11$1.38$1.20